The purpose of this study was to compare the diagnostic performance of the LI-RADS v2017 and v2018 for HCC in patients with cirrhosis using Gd-EOB-DTPA. We retrospectively analyzed Clinical data of 213 patients（246 observations）with cirrhosis who underwent Gd-EOB-DTPA from October 2015 to July 2020 were retrospectively collected. MRI major features were reviewed by two radiologists. The LI-RADS categories were assigned according to v2017 and v2018. Our study showed that Updated LR-5 criteria on Gd-EOB-DTPA, the diagnostic performance of LI-RADS v2018 for diagnosing HCC is superior to v2017, particularly in small HCC (10–19 mm), with a greater sensitivity and similar specificity.
This abstract and the presentation materials are available to members only; a login is required.